Extravasation of macromolecules

被引:112
作者
Takakura, Y [1 ]
Mahato, RI [1 ]
Hashida, M [1 ]
机构
[1] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Drug Delivery Res, Sakyo Ku, Kyoto 6068501, Japan
关键词
extravasation; macromolecules; pharmacokinetics; proteins; oligonucleotides; plasmid DNA;
D O I
10.1016/S0169-409X(98)00006-4
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Macromolecules can extravasate across the normal endothelium by transcapillary pinocytosis as well as by passage through interendothelial cell junctions, gaps or fenestrae. The main biological factors that control extravasation of a solute include regional differences in the capillary structures, the disease state of the organ or tissue, and the rate of blood and lymph supply. Physicochemical properties that are of profound significance in the extravasation of macromolecules are molecular size, shape, charge and hydrophilic/lipophilic balance (HLB) characteristics. Extravasation of small drugs, proteins, oligonucleotides and genes can be controlled by conjugating or forming complexes with macromolecular carriers. This requires a thorough understanding of the relationship between the chemical structures, physicochemical properties and the pharmacokinetics of both carrier and active molecules. This review article discusses the extravasation of macromolecules from the view points of pharmacokinetics and drug delivery systems, with the main emphasis on the extravasation across the liver, kidney and tumor capillaries. (C) 1998 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:93 / 108
页数:16
相关论文
共 100 条
[41]   Physicochemical and disposition characteristics of antisense oligonucleotides complexed with glycosylated poly(L-lysine) [J].
Mahato, RI ;
Takemura, S ;
Akamatsu, K ;
Nishikawa, M ;
Takakura, Y ;
Hashida, M .
BIOCHEMICAL PHARMACOLOGY, 1997, 53 (06) :887-895
[42]  
Mahato RI, 1997, CRIT REV THER DRUG, V14, P133
[43]  
Malik A.B., 1993, Biological Barriers to Protein Delivery, P231, DOI DOI 10.1007/978-1-4615-2898-2_10
[44]  
MATSUMURA Y, 1986, CANCER RES, V46, P6387
[45]  
MIHARA K, 1993, BIOL PHARM BULL, V16, P158
[46]   DISPOSITION CHARACTERISTICS OF PROTEIN DRUGS IN THE PERFUSED RAT-KIDNEY [J].
MIHARA, K ;
HOJO, T ;
FUJIKAWA, M ;
TAKAKURA, Y ;
SEZAKI, H ;
HASHIDA, M .
PHARMACEUTICAL RESEARCH, 1993, 10 (06) :823-827
[47]  
MIHARA K, 1994, BIOL PHARM BULL, V17, P296
[48]   STABILITY AND PHARMACOKINETIC CHARACTERISTICS OF OLIGONUCLEOTIDES MODIFIED AT TERMINAL LINKAGES IN MICE [J].
MIYAO, T ;
TAKAKURA, Y ;
AKIYAMA, T ;
YONEDA, F ;
SEZAKI, H ;
HASHIDA, M .
ANTISENSE RESEARCH AND DEVELOPMENT, 1995, 5 (02) :115-121
[49]  
NISHIDA K, 1990, INT J PHARM, V65, P7
[50]   HEPATIC DISPOSITION CHARACTERISTICS OF ELECTRICALLY CHARGED MACROMOLECULES IN RAT INVIVO AND IN THE PERFUSED LIVER [J].
NISHIDA, K ;
MIHARA, K ;
TAKINO, T ;
NAKANE, S ;
TAKAKURA, Y ;
HASHIDA, M ;
SEZAKI, H .
PHARMACEUTICAL RESEARCH, 1991, 8 (04) :437-444